MGMT and glioblastoma: Studies have also shown lower O-6-Methylguanine-DNA Methyltransferase (MGMT) expression and MGMT promoter methylation to be associated with improved response to temozolomide-based chemotherapy in PNETs, similar to the utility of MGMT status in glioblastoma [26,27,28].